Delivering high quality affordable medicines to millions of patients worldwide

Glenmark has worked towards improving the lives of patients globally. In the pursuit of this mission, Glenmark has focused on building a global Innovative/Specialty, Generics and OTC business in the therapy areas of Dermatology, Respiratory and Oncology. It also has strong regional/country-specific presence in other therapeutic areas like diabetes, cardiovascular and oral contraceptives.

Research & Development
Innovation is at the core of everything we do. It has been our endeavor to continuously innovate to improve lives of patients globally. In this quest, Glenmark is committed to address needs in the therapy areas of dermatology, oncology andrespiratory. Today we have a strong pipeline of specialty products and innovative molecules. Click here to view our Specialty/Innovative R&D Pipeline.

Focus on high quality formulations
Glenmark has focused on developing branded and generic formulations for over 4 decades positively impacting lives globally. In branded formulations, we are focused on developing innovative products for markets such as India, Russia & CIS, Brazil, Asia and Africa. The focus has been to develop products across dermatology, respiratory, cardio-metabolic therapy areas for the patients. In generics, we are developing high quality affordable products for markets such as US and Europe.

Active Pharmaceutical Ingredients
Glenmark's API business, an independent subsidiary called Glenmark Life Sciences, manufactures and supplies over 130 molecules to more than 700 customers.Glenmark partners with leading global generic companies, by supporting partnerships through advanced process chemistry skills and innovative intellectual property. Our API business spans over 65 countries including regulated markets of the US, Canada, Europe and Japan. Glenmark is a market leader for many API products in semi-regulated markets and has also established a leadership position with its first-to-file offerings in regulated markets.